Health Center » In The News » News Briefs 2007

FDA warns of Fatalities Linked to Imaging Drug

A Bristol-Myers Squibb Co. drug known as Definity, used to enhance ultrasound imaging of the heart, will carry a new warning about serious cardiopulmonary reactions and deaths associated with the product.  The FDA posted a new label carrying its strictest black-box warning on its Web site.  Bristol-Myers said it would notify the health-care professionals about the warnings.  A company spokesman said its received four reports of death linked to the drug out of two million patients in the U.S. since 2001.

Infinite Health Resources does not at any point, for any circumstances suggest that you do not follow or stop medical advice of your physician. We do not advocate any drugs that has not been prescribed by your physician, nor suggest that we are medical doctors nor are we giving medical advice. Infinite Health Resources is here purely as a resource.